Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

3.2K
Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
3.2K
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

723
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
723
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

429
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
429
Alterations in Blood Pressure01:30

Alterations in Blood Pressure

1.2K
Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
1.2K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

625
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
625

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of Dementia and Modifiable Risk Factors among Older Adults in Cuba: A Population-Based Study.

Neuroepidemiology·2026
Same author

Prospective association between long COVID and COVID-related post-traumatic stress disorder among a population-based cohort of adults diagnosed with COVID-19 in Michigan.

Journal of affective disorders·2026
Same author

Financial Protection in Flux: Longitudinal Evidence on Out-of-Pocket Spending Among Middle-Aged and Older Mexicans During the Seguro Popular-INSABI Transition.

Health policy and planning·2026
Same author

Special issue: Hispanic/Latinx healthy aging.

The Gerontologist·2026
Same author

Emigration and Cognitive Aging Among Mexican Return Migrants.

Hispanic journal of behavioral sciences·2026
Same author

Bilingualism was not associated with a cognitive advantage among older Mexican adults.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026

Related Experiment Video

Updated: Jul 1, 2025

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.2K

Do conditional cash transfers reduce hypertension?

Emma Aguila1, William H Dow2, Felipe Menares3

  • 1Sol Price School of Public Policy, University of Southern California, Los Angeles, CA, USA.

Economics and Human Biology
|March 5, 2024
PubMed
Summary

Conditional cash transfer programs like Progresa improve hypertension diagnosis and medication use in older adults. However, the program alone did not significantly reduce uncontrolled hypertension without additional healthcare support.

Keywords:
Conditional cash transfersElderlyHealthHypertensionMexico

More Related Videos

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells
09:29

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells

Published on: March 5, 2019

5.8K
Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

730

Related Experiment Videos

Last Updated: Jul 1, 2025

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.2K
Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells
09:29

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells

Published on: March 5, 2019

5.8K
Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

730

Area of Science:

  • Public Health
  • Health Economics
  • Gerontology

Background:

  • Conditional cash transfer (CCT) programs are widely adopted globally.
  • Progresa is a notable anti-poverty CCT program with documented benefits for children and adolescents.
  • The impact of CCTs on the health of older adults remains under-researched.

Purpose of the Study:

  • To analyze the effects of the Progresa program on the health of middle-aged and older adult beneficiaries.
  • To specifically investigate the impact on hypertension, a prevalent chronic condition.

Main Methods:

  • Analysis of household survey data focusing on middle-aged and older adults.
  • Examination of hypertension diagnosis rates and medication adherence.
  • Biomarker measurements (systolic and diastolic blood pressure) to assess hypertension control.

Main Results:

  • Progresa demonstrated significant positive effects on hypertension diagnosis rates.
  • Beneficiaries showed increased utilization of hypertension treatment drugs.
  • No significant improvements were observed in uncontrolled hypertension based on blood pressure biomarkers.

Conclusions:

  • While Progresa enhances access to healthcare and medications, it may not independently improve hypertension control in older adults.
  • Complementary healthcare system follow-up is crucial for medication adherence and effective hypertension management.
  • CCT programs require integration with healthcare services for optimal chronic disease outcomes.